Status epilepticus is associated with significant morbidity and mortality. Benzodiazepines are recommended as first line agents but their efficacy is approximately 50%. The most commonly recommended 2nd line agents are Phenytoin and Fosphenytoin.
Read More
Tagged ‘Neurology’
Journal Review
Levetiracetam versus Phenytoin for Second-Line Treatment of Convulsive Status Epilepticus in Children (ConSEPT): An Open-Label, Multicentre, Randomised Trial
Core
Cauda Equina Syndrome
This post reviews the rare but high-associated morbidity diagnosis of cauda equina syndrome.
Read More
Journal Review
Tenecteplase vs Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)
This review is cross-posted on REBEL EM.
Alteplase is a tissue plasminogen activator that is approved for use prior to thrombectomy in ischemic strokes with the goal of reperfusion to ischemic areas of the brain.
Read More
Core
Wernicke Encephalopathy
This post explores Wernicke Encephalopathy with a focus on diagnosis and management.
Read More
Journal Review
The VAN Assessment to Identify Large Vessel Occlusion Strokes
This review is cross-posted on REBEL EM.
Over the last three years, we have seen the rise of neurointerventional therapies for patients with ischemic strokes due to large vessel occlusions (LVOs).
Read More